🔎 Trials Near Me

ホーム › 乳がん › バーモント

バーモントにおける乳がんの臨床試験

バーモント内の拠点で、乳がんに関する6件の研究が参加者を募集しています。

バーモント内の都市

公式研究テキスト(英語)

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • The University of Vermont Medical Center Inc., Burlington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • The University of Vermont Medical Center Inc., Burlington
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07287098

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • University of Vermont Medical Center, Burlington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • University of Vermont Medical Center, Burlington
  • University of Vermont and State Agricultural College, Burlington
  • Dartmouth Cancer Center - North, Saint Johnsbury
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Central Vermont Medical Center, Berlin Corners
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。